HEADER PEPTIDE BINDING PROTEIN 29-APR-19 6RJP TITLE BFL-1 IN COMPLEX WITH ALPHA HELICAL PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-2-RELATED PROTEIN A1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BCL-2-LIKE PROTEIN 5,BCL2-L-5,HEMOPOIETIC-SPECIFIC EARLY COMPND 5 RESPONSE PROTEIN,PROTEIN BFL-1,PROTEIN GRS; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BCL-2-LIKE PROTEIN 11; COMPND 9 CHAIN: C, D; COMPND 10 SYNONYM: BCL2-L-11,BCL2-INTERACTING MEDIATOR OF CELL DEATH; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: THIS IS MODIFIED AMINO ACIDS. MADE TO GET A TETHERED COMPND 13 PEPTIDE PRODUCED WITH COVALENT BONDS. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2A1, BCL2L5, BFL1, GRS, HBPA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS PROTEIN-PROTEIN INTERACTIONS, STAPLED ALPHA HELIX, COVALENT KEYWDS 2 INHIBITOR, BCL2-2 FAMILY PROTEINS, PEPTIDE BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.BAGGIO,L.GAMBINI,P.UDOMPHOLKUL,A.F.SALEM,M.HAKANSSON,J.JOSSART, AUTHOR 2 J.PERRY,M.PELLECCHIA REVDAT 5 24-JAN-24 6RJP 1 LINK REVDAT 4 30-MAR-22 6RJP 1 REMARK LINK REVDAT 3 25-MAR-20 6RJP 1 JRNL REVDAT 2 15-JAN-20 6RJP 1 JRNL REVDAT 1 30-OCT-19 6RJP 0 JRNL AUTH C.BAGGIO,P.UDOMPHOLKUL,L.GAMBINI,J.JOSSART,A.F.SALEM, JRNL AUTH 2 M.HAKANSSON,J.J.P.PERRY,M.PELLECCHIA JRNL TITL N-LOCKING STABILIZATION OF COVALENT HELICAL PEPTIDES: JRNL TITL 2 APPLICATION TO BFL-1 ANTAGONISTS. JRNL REF CHEM.BIOL.DRUG DES. V. 95 412 2020 JRNL REFN ESSN 1747-0285 JRNL PMID 31898401 JRNL DOI 10.1111/CBDD.13661 REMARK 2 REMARK 2 RESOLUTION. 2.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 55.6 REMARK 3 NUMBER OF REFLECTIONS : 10097 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 555 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 3.54 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 49 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 48 REMARK 3 BIN R VALUE (WORKING SET) : 0.2740 REMARK 3 BIN FREE R VALUE : 0.5320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2694 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 10 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 118.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.94000 REMARK 3 B22 (A**2) : -0.94000 REMARK 3 B33 (A**2) : 3.06000 REMARK 3 B12 (A**2) : -0.47000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: A 0 A 149 REMARK 3 ORIGIN FOR THE GROUP (A): 45.4730 -32.5900 4.8680 REMARK 3 T TENSOR REMARK 3 T11: 0.2790 T22: 0.0726 REMARK 3 T33: 0.0774 T12: -0.0350 REMARK 3 T13: 0.0794 T23: 0.0017 REMARK 3 L TENSOR REMARK 3 L11: 3.3570 L22: 3.3179 REMARK 3 L33: 2.8946 L12: 1.6047 REMARK 3 L13: -0.2128 L23: -1.1985 REMARK 3 S TENSOR REMARK 3 S11: 0.1275 S12: 0.2235 S13: 0.0499 REMARK 3 S21: 0.3069 S22: 0.0458 S23: 0.4194 REMARK 3 S31: 0.0699 S32: 0.1976 S33: -0.1733 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: B 0 B 149 REMARK 3 ORIGIN FOR THE GROUP (A): 32.6640 -55.3830 -4.5760 REMARK 3 T TENSOR REMARK 3 T11: 0.4179 T22: 0.4670 REMARK 3 T33: 0.5503 T12: -0.4152 REMARK 3 T13: 0.1119 T23: -0.2027 REMARK 3 L TENSOR REMARK 3 L11: 2.6598 L22: 7.3971 REMARK 3 L33: 1.3324 L12: 3.5623 REMARK 3 L13: 1.8592 L23: 2.7509 REMARK 3 S TENSOR REMARK 3 S11: -0.5792 S12: 0.6746 S13: -0.6626 REMARK 3 S21: -0.5895 S22: 1.0747 S23: -1.5485 REMARK 3 S31: -0.4171 S32: 0.5193 S33: -0.4955 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: C 1 C 17 REMARK 3 ORIGIN FOR THE GROUP (A): 49.1390 -25.0800 16.1100 REMARK 3 T TENSOR REMARK 3 T11: 0.9756 T22: 0.4415 REMARK 3 T33: 0.1134 T12: -0.3137 REMARK 3 T13: 0.1941 T23: -0.0593 REMARK 3 L TENSOR REMARK 3 L11: 6.8802 L22: 3.1680 REMARK 3 L33: 3.0161 L12: 1.2606 REMARK 3 L13: 0.1067 L23: -1.8413 REMARK 3 S TENSOR REMARK 3 S11: 0.6352 S12: -1.0956 S13: 0.1299 REMARK 3 S21: 1.1671 S22: -0.5741 S23: 0.5014 REMARK 3 S31: -0.7752 S32: 0.5009 S33: -0.0611 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: D 1 D 17 REMARK 3 ORIGIN FOR THE GROUP (A): 28.3000 -63.0990 -16.0520 REMARK 3 T TENSOR REMARK 3 T11: 0.7978 T22: 0.9690 REMARK 3 T33: 0.7490 T12: -0.4945 REMARK 3 T13: 0.2778 T23: -0.5361 REMARK 3 L TENSOR REMARK 3 L11: 9.4755 L22: 5.4468 REMARK 3 L33: 3.2008 L12: -0.6453 REMARK 3 L13: 3.0077 L23: -3.6178 REMARK 3 S TENSOR REMARK 3 S11: 0.0432 S12: 1.8416 S13: -0.9138 REMARK 3 S21: -0.0495 S22: -0.2336 S23: -0.8232 REMARK 3 S31: -0.2231 S32: 0.8007 S33: 0.1904 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 6RJP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-APR-19. REMARK 100 THE DEPOSITION ID IS D_1292102018. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.975312 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10669 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 61.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 55.5 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.94 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.68500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2VM6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE PH 4.6 16% (W/V) REMARK 280 PEG SMEAR HIGH, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 26.38267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 52.76533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 52.76533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 26.38267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 SER A -14 REMARK 465 SER A -13 REMARK 465 GLY A -12 REMARK 465 VAL A -11 REMARK 465 ASP A -10 REMARK 465 LEU A -9 REMARK 465 GLY A -8 REMARK 465 THR A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 PHE A -2 REMARK 465 GLN A -1 REMARK 465 MET B -21 REMARK 465 HIS B -20 REMARK 465 HIS B -19 REMARK 465 HIS B -18 REMARK 465 HIS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 SER B -14 REMARK 465 SER B -13 REMARK 465 GLY B -12 REMARK 465 VAL B -11 REMARK 465 ASP B -10 REMARK 465 LEU B -9 REMARK 465 GLY B -8 REMARK 465 THR B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N LV8 D 1 OE2 GLU D 4 1.96 REMARK 500 N LV8 C 1 OE1 GLU C 4 2.12 REMARK 500 O ARG B 88 OG1 THR B 91 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 96 CD GLU A 96 OE1 0.068 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 137 51.36 -115.43 REMARK 500 SER B 28 6.68 -65.33 REMARK 500 PHE B 79 50.55 -96.71 REMARK 500 ASN B 137 54.15 -109.91 REMARK 500 GLU D 4 -70.54 -41.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 28 GLY A 29 -140.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 35 0.11 SIDE CHAIN REMARK 500 ARG A 105 0.09 SIDE CHAIN REMARK 500 ARG B 35 0.10 SIDE CHAIN REMARK 500 ARG C 7 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 6RJP A 1 149 UNP Q16548 B2LA1_HUMAN 1 149 DBREF 6RJP B 1 149 UNP Q16548 B2LA1_HUMAN 1 149 DBREF 6RJP C 1 17 UNP O43521 B2L11_HUMAN 147 163 DBREF 6RJP D 1 17 UNP O43521 B2L11_HUMAN 147 163 SEQADV 6RJP MET A -21 UNP Q16548 INITIATING METHIONINE SEQADV 6RJP HIS A -20 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS A -19 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS A -18 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS A -17 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS A -16 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS A -15 UNP Q16548 EXPRESSION TAG SEQADV 6RJP SER A -14 UNP Q16548 EXPRESSION TAG SEQADV 6RJP SER A -13 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLY A -12 UNP Q16548 EXPRESSION TAG SEQADV 6RJP VAL A -11 UNP Q16548 EXPRESSION TAG SEQADV 6RJP ASP A -10 UNP Q16548 EXPRESSION TAG SEQADV 6RJP LEU A -9 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLY A -8 UNP Q16548 EXPRESSION TAG SEQADV 6RJP THR A -7 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLU A -6 UNP Q16548 EXPRESSION TAG SEQADV 6RJP ASN A -5 UNP Q16548 EXPRESSION TAG SEQADV 6RJP LEU A -4 UNP Q16548 EXPRESSION TAG SEQADV 6RJP TYR A -3 UNP Q16548 EXPRESSION TAG SEQADV 6RJP PHE A -2 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLN A -1 UNP Q16548 EXPRESSION TAG SEQADV 6RJP SER A 0 UNP Q16548 EXPRESSION TAG SEQADV 6RJP MET B -21 UNP Q16548 INITIATING METHIONINE SEQADV 6RJP HIS B -20 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS B -19 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS B -18 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS B -17 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS B -16 UNP Q16548 EXPRESSION TAG SEQADV 6RJP HIS B -15 UNP Q16548 EXPRESSION TAG SEQADV 6RJP SER B -14 UNP Q16548 EXPRESSION TAG SEQADV 6RJP SER B -13 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLY B -12 UNP Q16548 EXPRESSION TAG SEQADV 6RJP VAL B -11 UNP Q16548 EXPRESSION TAG SEQADV 6RJP ASP B -10 UNP Q16548 EXPRESSION TAG SEQADV 6RJP LEU B -9 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLY B -8 UNP Q16548 EXPRESSION TAG SEQADV 6RJP THR B -7 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLU B -6 UNP Q16548 EXPRESSION TAG SEQADV 6RJP ASN B -5 UNP Q16548 EXPRESSION TAG SEQADV 6RJP LEU B -4 UNP Q16548 EXPRESSION TAG SEQADV 6RJP TYR B -3 UNP Q16548 EXPRESSION TAG SEQADV 6RJP PHE B -2 UNP Q16548 EXPRESSION TAG SEQADV 6RJP GLN B -1 UNP Q16548 EXPRESSION TAG SEQADV 6RJP SER B 0 UNP Q16548 EXPRESSION TAG SEQADV 6RJP LV8 C 1 UNP O43521 TRP 147 ENGINEERED MUTATION SEQADV 6RJP GLU C 4 UNP O43521 GLN 150 CONFLICT SEQADV 6RJP ALA C 5 UNP O43521 GLU 151 CONFLICT SEQADV 6RJP ALA C 12 UNP O43521 GLU 158 CONFLICT SEQADV 6RJP ALA C 16 UNP O43521 TYR 162 CONFLICT SEQADV 6RJP LV8 D 1 UNP O43521 TRP 147 ENGINEERED MUTATION SEQADV 6RJP GLU D 4 UNP O43521 GLN 150 CONFLICT SEQADV 6RJP ALA D 5 UNP O43521 GLU 151 CONFLICT SEQADV 6RJP ALA D 12 UNP O43521 GLU 158 CONFLICT SEQADV 6RJP ALA D 16 UNP O43521 TYR 162 CONFLICT SEQRES 1 A 171 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 171 GLY THR GLU ASN LEU TYR PHE GLN SER MET THR ASP CYS SEQRES 3 A 171 GLU PHE GLY TYR ILE TYR ARG LEU ALA GLN ASP TYR LEU SEQRES 4 A 171 GLN CYS VAL LEU GLN ILE PRO GLN PRO GLY SER GLY PRO SEQRES 5 A 171 SER LYS THR SER ARG VAL LEU GLN ASN VAL ALA PHE SER SEQRES 6 A 171 VAL GLN LYS GLU VAL GLU LYS ASN LEU LYS SER CYS LEU SEQRES 7 A 171 ASP ASN VAL ASN VAL VAL SER VAL ASP THR ALA ARG THR SEQRES 8 A 171 LEU PHE ASN GLN VAL MET GLU LYS GLU PHE GLU ASP GLY SEQRES 9 A 171 ILE ILE ASN TRP GLY ARG ILE VAL THR ILE PHE ALA PHE SEQRES 10 A 171 GLU GLY ILE LEU ILE LYS LYS LEU LEU ARG GLN GLN ILE SEQRES 11 A 171 ALA PRO ASP VAL ASP THR TYR LYS GLU ILE SER TYR PHE SEQRES 12 A 171 VAL ALA GLU PHE ILE MET ASN ASN THR GLY GLU TRP ILE SEQRES 13 A 171 ARG GLN ASN GLY GLY TRP GLU ASN GLY PHE VAL LYS LYS SEQRES 14 A 171 PHE GLU SEQRES 1 B 171 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 171 GLY THR GLU ASN LEU TYR PHE GLN SER MET THR ASP CYS SEQRES 3 B 171 GLU PHE GLY TYR ILE TYR ARG LEU ALA GLN ASP TYR LEU SEQRES 4 B 171 GLN CYS VAL LEU GLN ILE PRO GLN PRO GLY SER GLY PRO SEQRES 5 B 171 SER LYS THR SER ARG VAL LEU GLN ASN VAL ALA PHE SER SEQRES 6 B 171 VAL GLN LYS GLU VAL GLU LYS ASN LEU LYS SER CYS LEU SEQRES 7 B 171 ASP ASN VAL ASN VAL VAL SER VAL ASP THR ALA ARG THR SEQRES 8 B 171 LEU PHE ASN GLN VAL MET GLU LYS GLU PHE GLU ASP GLY SEQRES 9 B 171 ILE ILE ASN TRP GLY ARG ILE VAL THR ILE PHE ALA PHE SEQRES 10 B 171 GLU GLY ILE LEU ILE LYS LYS LEU LEU ARG GLN GLN ILE SEQRES 11 B 171 ALA PRO ASP VAL ASP THR TYR LYS GLU ILE SER TYR PHE SEQRES 12 B 171 VAL ALA GLU PHE ILE MET ASN ASN THR GLY GLU TRP ILE SEQRES 13 B 171 ARG GLN ASN GLY GLY TRP GLU ASN GLY PHE VAL LYS LYS SEQRES 14 B 171 PHE GLU SEQRES 1 C 17 LV8 ILE AIB GLU ALA LEU ARG ARG ILE GLY ASP ALA PHE SEQRES 2 C 17 ASN ALA ALA TYR SEQRES 1 D 17 LV8 ILE AIB GLU ALA LEU ARG ARG ILE GLY ASP ALA PHE SEQRES 2 D 17 ASN ALA ALA TYR MODRES 6RJP AIB C 3 ALA MODIFIED RESIDUE MODRES 6RJP AIB D 3 ALA MODIFIED RESIDUE HET LV8 C 1 9 HET AIB C 3 6 HET LV8 D 1 9 HET AIB D 3 6 HETNAM LV8 (2~{S})-3-ACETAMIDO-2-AZANYL-PROPANOIC ACID HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID FORMUL 3 LV8 2(C5 H10 N2 O3) FORMUL 3 AIB 2(C4 H9 N O2) FORMUL 5 HOH *10(H2 O) HELIX 1 AA1 SER A 0 LEU A 21 1 22 HELIX 2 AA2 SER A 31 LEU A 52 1 22 HELIX 3 AA3 LEU A 52 ASP A 57 1 6 HELIX 4 AA4 SER A 63 PHE A 79 1 17 HELIX 5 AA5 ASN A 85 GLN A 107 1 23 HELIX 6 AA6 TYR A 115 THR A 130 1 16 HELIX 7 AA7 THR A 130 ASN A 137 1 8 HELIX 8 AA8 PHE A 144 GLU A 149 1 6 HELIX 9 AA9 MET B 1 LEU B 21 1 21 HELIX 10 AB1 SER B 31 LEU B 52 1 22 HELIX 11 AB2 LEU B 52 ASP B 57 1 6 HELIX 12 AB3 SER B 63 PHE B 79 1 17 HELIX 13 AB4 ASN B 85 GLN B 107 1 23 HELIX 14 AB5 TYR B 115 THR B 130 1 16 HELIX 15 AB6 THR B 130 ASN B 137 1 8 HELIX 16 AB7 PHE B 144 GLU B 149 1 6 HELIX 17 AB8 ILE C 2 TYR C 17 1 16 HELIX 18 AB9 ILE D 2 TYR D 17 1 16 SSBOND 1 CYS A 4 CYS B 4 1555 1555 2.07 LINK SG CYS A 55 CE LV8 C 1 1555 1555 1.69 LINK SG CYS B 55 CE LV8 D 1 1555 1555 1.63 LINK C LV8 C 1 N ILE C 2 1555 1555 1.34 LINK N LV8 C 1 CD GLU C 4 1555 1555 1.30 LINK C ILE C 2 N AIB C 3 1555 1555 1.34 LINK C AIB C 3 N GLU C 4 1555 1555 1.34 LINK C LV8 D 1 N ILE D 2 1555 1555 1.34 LINK N LV8 D 1 CD GLU D 4 1555 1555 1.32 LINK C ILE D 2 N AIB D 3 1555 1555 1.35 LINK C AIB D 3 N GLU D 4 1555 1555 1.34 CRYST1 113.749 113.749 79.148 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008791 0.005076 0.000000 0.00000 SCALE2 0.000000 0.010151 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012635 0.00000